Skip to main content

MoneyWorks4Me

A decrease in the sales to Rs. 191.11 millions was observed for the quarter ended June 2025. The sales stood at Rs. 214.44 millions during the similar quarter previous year.The Net Profit of the company vaulted to 129.80% to Rs. 117.77  millions from Rs. 51.25 millions in the previous quarter.OP of the company witnessed a marginal growth to 123.83 millions from 57.03 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 191.11 214.44 -10.88 191.11 214.44 -10.88 1116.45 1087.39 2.67
Other Income 119.58 51.60 131.74 119.58 51.60 131.74 241.12 148.74 62.11
PBIDT 123.83 57.03 117.13 123.83 57.03 117.13 283.10 230.18 22.99
Interest 0.53 0.53 0.00 0.53 0.53 0.00 2.66 3.89 -31.62
PBDT 123.30 56.68 117.54 123.30 56.68 117.54 280.44 226.29 23.93
Depreciation 5.53 5.43 1.84 5.53 5.43 1.84 22.02 19.55 12.63
PBT 117.77 51.25 129.80 117.77 51.25 129.80 258.42 206.74 25.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 61.62 38.97 58.12
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 20.98 1.13 1756.64
PAT 117.77 51.25 129.80 117.77 51.25 129.80 196.80 167.77 17.30
Equity 210.41 210.41 0.00 210.41 210.41 0.00 210.41 210.41 0.00
PBIDTM(%) 64.80 26.59 143.64 64.80 26.59 143.64 25.36 21.17 19.79
Peers
Company Name CMP
Sun Pharma. Inds. 1925.70
Dr. Reddys Labs. 1383.00
Cipla 1409.00
Lupin 2019.00
Zydus Lifesciences 1221.80
View more..